Bulletin
Investor Alert

New York Markets After Hours

Evotec SE ADR

OTC: EVTCY

GO
/marketstate/country/us

Market closed

/zigman2/quotes/202830589/composite

$

53.20

Change

+0.25 +0.47%

Volume

Volume 12

Sep 24, 2020, 5:20 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202830589/composite

Previous close

$ 52.95

$ 53.20

Change

+0.25 +0.47%

Day low

Day high

$53.20

$53.20

Open
Open: 53.20

52 week low

52 week high

$40.42

$59.91

Open

Market cap

$3.88B

Average volume

284.78

P/E ratio

105.33

Rev. per Employee

$195,050

EPS

0.51

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/evtcy

MarketWatch News on EVTCY

  1. Evotec gets DoD contract to develop Covid-19 drug

    2:25 a.m. July 22, 2020

    - MarketWatch.com

  2. Evotec shares jump on Sanofi agreement

    6:35 a.m. June 18, 2018

    - MarketWatch.com

  3. Sanofi, Evotec in talks to create R&D platform

    4:02 a.m. March 8, 2018

    - MarketWatch.com

  4. Sanofi, Evotec, Apeiron make cancer-therapy deal

    2:37 a.m. Aug. 10, 2015

    - MarketWatch.com

  5. Sanofi partners with Evotec on diabetes therapies

    2:32 a.m. Aug. 7, 2015

    - MarketWatch.com

  6. Evotec, Roche's Genentech in drug-discovery pact

    2:08 a.m. May 10, 2010

    - Robert Daniel

  7. Monday's biggest gaining and declining stocks

    6:21 p.m. March 9, 2009

    - MarketWatch

  8. Evotec signs drug development deal with Roche

    6:50 a.m. March 9, 2009

    - Sarah Turner

  9. Roche could pay Evotec over $300 mln on EVT 101

    6:47 a.m. March 9, 2009

    - Steve Goldstein

  10. Evotec, Roche reach deal on EVT 101 development

    6:47 a.m. March 9, 2009

    - Steve Goldstein

/news/nonmarketwatch/company/us/evtcy

Other News on EVTCY

  1. Centogene and Evotec expand collaboration into Gaucher disease

    3:11 a.m. Aug. 20, 2020

    - Seeking Alpha

  2. Novo teams up with Evotec in kidney diseases

    6:08 a.m. Aug. 18, 2020

    - Seeking Alpha

  3. Evotec SE 2020 Q2 - Results - Earnings Call Presentation

    9:49 a.m. Aug. 12, 2020

    - Seeking Alpha

  4. Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?

    9:15 a.m. July 21, 2020

    - Zacks.com

  5. Evotec partners with Quantro Therapeutics

    3:24 a.m. July 21, 2020

    - Seeking Alpha

  6. Pacira (PCRX) Hits 52-Week High, Can the Run Continue?

    9:15 a.m. July 2, 2020

    - Zacks.com

  7. Evotec participates in Exscientia's financing round

    7:49 a.m. May 26, 2020

    - Seeking Alpha

  8. Evotec regains global rights to Beta Cell Replacement Therapy

    9:59 a.m. April 22, 2020

    - Seeking Alpha

  9. Evotec inks drug development deal with Ildong Pharmaceutical

    6:55 a.m. March 31, 2020

    - Seeking Alpha

  10. Evotec SE 2019 Q4 - Results - Earnings Call Presentation

    9:01 a.m. March 26, 2020

    - Seeking Alpha

  11. Evotec teams up with Takeda in drug discovery

    7:03 a.m. Sept. 24, 2019

    - Seeking Alpha

  12. Loading more headlines...
/news/pressrelease/company/us/evtcy

Press Releases on EVTCY

  1. Evotec Enters Partnership with Quantro Therapeutics

    1:40 a.m. July 21, 2020

    - ACCESSWIRE

  2. Evotec Initiates 'Campus Curie' In Toulouse

    1:50 a.m. July 8, 2020

    - ACCESSWIRE

  3. Evotec, Samsara BioCapital, And KCK Launch Autobahn Labs

    7:33 a.m. June 24, 2020

    - ACCESSWIRE

  4. Evotec Participates in Exscientia's Financing Round

    1:46 a.m. May 26, 2020

    - ACCESSWIRE

  5. Pharmacokinetics Services Market Outlook: 2020 the Year on a Positive Note

    8:08 a.m. May 14, 2020

    - HTF Market Intelligence

  6. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.